Characteristics | LMA® Gastro™ | Low Flow Nasal cannula | Endotracheal Tube (ETT) |
---|---|---|---|
Number of cases (n) | 64 | 85 | 28 |
Demographics | |||
Male/Female | 28/36 | 37/48 | 10/18 |
Age (years) | 66 (27–91) | 73 (19–95) | 78 (18–94) |
Average BMI kg/m2 | 29 (18–44) | 28 (17–44) | 29 (18–77) |
Nature of ERCP | |||
Elective | 37 | 52 | 8 |
Emergency | 26 | 35 | 20 |
ASA Status 1/2/3/4/5 | 3/22/32/5/0 | 17/26/35/7/0 | 1/3/18/6/1 |
Airway conversion to ETT | 1 | 1 | N/A |
Intraoperative SpO2 < 92% | 0 | 1 | 0 |
Lowest Intraoperative SpO2 | 98 (92–100) | 98 (89–100) | 98 (92–100) |
Vasopressor/inotropic/vagolytic use | |||
Atropine | 1 | 0 | 1 |
Adrenaline | 1 | 0 | 1 |
Ephedrine | 0 | 1 | 1 |
Metaraminol | 15 | 5 | 9 |
Noradrenaline | 1 | 0 | 3 |
Mean Duration of Anaesthesia (in minutes) | 57 | 51 | 71 |
ERCP Failure | 6 | 2 | 0 |
Adverse Intraoperative Eventsa | 2 | 3 | 0 |
Adverse 24 h Postoperative (PACU) eventsb | 2 | 1 | 3 |